Your browser doesn't support javascript.
loading
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
Berndt, Sonja I; Vijai, Joseph; Benavente, Yolanda; Camp, Nicola J; Nieters, Alexandra; Wang, Zhaoming; Smedby, Karin E; Kleinstern, Geffen; Hjalgrim, Henrik; Besson, Caroline; Skibola, Christine F; Morton, Lindsay M; Brooks-Wilson, Angela R; Teras, Lauren R; Breeze, Charles; Arias, Joshua; Adami, Hans-Olov; Albanes, Demetrius; Anderson, Kenneth C; Ansell, Stephen M; Bassig, Bryan; Becker, Nikolaus; Bhatti, Parveen; Birmann, Brenda M; Boffetta, Paolo; Bracci, Paige M; Brennan, Paul; Brown, Elizabeth E; Burdett, Laurie; Cannon-Albright, Lisa A; Chang, Ellen T; Chiu, Brian C H; Chung, Charles C; Clavel, Jacqueline; Cocco, Pierluigi; Colditz, Graham; Conde, Lucia; Conti, David V; Cox, David G; Curtin, Karen; Casabonne, Delphine; De Vivo, Immaculata; Diepstra, Arjan; Diver, W Ryan; Dogan, Ahmet; Edlund, Christopher K; Foretova, Lenka; Fraumeni, Joseph F; Gabbas, Attilio; Ghesquières, Hervé.
Afiliação
  • Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md, USA. berndts@mail.nih.gov.
  • Vijai J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Benavente Y; Cancer Epidemiology Research Programme, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Camp NJ; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Nieters A; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Wang Z; Institute for Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany.
  • Smedby KE; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Kleinstern G; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Hjalgrim H; Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Besson C; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Skibola CF; School of Public Health, University of Haifa, Haifa, Israel.
  • Morton LM; Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
  • Brooks-Wilson AR; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Teras LR; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
  • Breeze C; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
  • Arias J; Centre Hospitalier de Versailles, Le Chesnay, France.
  • Adami HO; Université Paris-Saclay, UVSQ, Inserm, Équipe "Exposome et Hérédité", CESP, Villejuif, France.
  • Albanes D; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Anderson KC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md, USA.
  • Ansell SM; Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.
  • Bassig B; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
  • Becker N; Department of Population Science, American Cancer Society, Atlanta, GA, USA.
  • Bhatti P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md, USA.
  • Birmann BM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md, USA.
  • Boffetta P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Bracci PM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Brennan P; Institute of Health and Society, Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
  • Brown EE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md, USA.
  • Burdett L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Cannon-Albright LA; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Chang ET; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md, USA.
  • Chiu BCH; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany.
  • Chung CC; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Clavel J; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Cocco P; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, 11794, NY, USA.
  • Colditz G; Department of Medical and Surgical Sciences, University of Bologna, Bologna, 41026, Italy.
  • Conde L; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
  • Conti DV; International Agency for Research on Cancer (IARC), Lyon, France.
  • Cox DG; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Curtin K; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MA, USA.
  • Casabonne D; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • De Vivo I; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA.
  • Diepstra A; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
  • Diver WR; Center for Health Sciences, Exponent, Inc., Menlo Park, CA, USA.
  • Dogan A; Department of Public Health Sciences University of Chicago, Chicago, IL, USA.
  • Edlund CK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md, USA.
  • Foretova L; CRESS, UMR1153, INSERM, Villejuif, France.
  • Fraumeni JF; Université de Paris-Cité, Villejuif, France.
  • Gabbas A; Centre for Occupational and Environmental Health, Division of Population Science, Health Services Research & Primary Care, University of Manchester, Manchester, United Kingdom.
  • Ghesquières H; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Leukemia ; 36(12): 2835-2844, 2022 12.
Article em En | MEDLINE | ID: mdl-36273105
ABSTRACT
Lymphoma risk is elevated for relatives with common non-Hodgkin lymphoma (NHL) subtypes, suggesting shared genetic susceptibility across subtypes. To evaluate the extent of mutual heritability among NHL subtypes and discover novel loci shared among subtypes, we analyzed data from eight genome-wide association studies within the InterLymph Consortium, including 10,629 cases and 9505 controls. We utilized Association analysis based on SubSETs (ASSET) to discover loci for subsets of NHL subtypes and evaluated shared heritability across the genome using Genome-wide Complex Trait Analysis (GCTA) and polygenic risk scores. We discovered 17 genome-wide significant loci (P < 5 × 10-8) for subsets of NHL subtypes, including a novel locus at 10q23.33 (HHEX) (P = 3.27 × 10-9). Most subset associations were driven primarily by only one subtype. Genome-wide genetic correlations between pairs of subtypes varied broadly from 0.20 to 0.86, suggesting substantial heterogeneity in the extent of shared heritability among subtypes. Polygenic risk score analyses of established loci for different lymphoid malignancies identified strong associations with some NHL subtypes (P < 5 × 10-8), but weak or null associations with others. Although our analyses suggest partially shared heritability and biological pathways, they reveal substantial heterogeneity among NHL subtypes with each having its own distinct germline genetic architecture.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Predisposição Genética para Doença Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Predisposição Genética para Doença Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos